Brief: Redwood Pharma Presents Positive Results From A Clinical Study With RP501 Against Dry Eye
May 31 (Reuters) - Redwood Pharma AB REDWPH.ST :
* REDWOOD PHARMA PRESENTS POSITIVE RESULTS FROM A CLINICAL
STUDY
WITH RP501 AGAINST DRY EYE
Source text for Eikon: ID:nWkr86TXRf
Further company coverage: REDWPH.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Redwood Pharma AB
See all newsBrief: Redwood Pharma Says Files For Bankruptcy
Brief: Redwood Pharma Provides New Update Regarding Divestment Of Company Assets
Brief: Redwood Pharma Updates On Process For Divesting Assets
Brief: Redwood Pharma To Propose Liquidation At EGM
Brief: Redwood Pharma: Minimum Level In Rights Issue Not Reached